HypoCCS Series Volume 9: Molecular Pathogenesis and Therapy of Pituitary Disease

Ken Ho and Kazuo Chihara
Hardback, 224 pages
ISBN–10 1 901978 26 5, ISBN-13 978-1-901978-26-1, €24.99/£16.50/US$31.99
Volume 9 in the HypoCCS symposia series
Published March 2006
ISSN 1 466-4151

Buy online

Contact us

This volume brings together leading authorities in the field of pituitary disease to discuss basic and clinical topics covering the mechanisms of pituitary disease, peripheral hormone action and new therapies.
Chapters cover pituitary developmental abnormalities and lessons learnt from growth hormone replacement in adults. There is a valuable insight into the functional interaction between peripheral hormones and the pituitary gland in the control of the metabolic process. In addition, comprehensive reviews on the role of androgens in women, the therapeutic potential of somatostatin analogues and glucocorticoid replacement are complemented by updates on Kallmann’s syndrome, craniopharyngiomas and the role of P27 in pituitary tumorigenesis.

Endocrine scientists and clinicians will find this volume a thorough review of the approaches and the mechanistic basis of pituitary disease. It represents excellence in current literature.

Chapters

• Pituitary developmental abnormalities: molecular basis of clinical phenotype
  J Drouin, A-M Pulichino, and S Vallette-Kasic, Institut de recherches clinique de Montréal, Canada
• Kallmann syndrome and FGF-insufficiency
  C Dodé, Institut Cochin et Laboratoire de Biochimie et Génétique Moléculaire and J-P Hardeli, Institut Pasteur, Paris, France
• p27Kip1 and G1 cell cycle machinery in pituitary tumorigenesis
  H Kiyokawa, Northwestern University, Chicago, USA
• Craniopharyngiomas: a clinicopathologic spectrum
  B W Scheithauer, Mayo Support Center South 1, USA
• 11?-Hydroxysteroid dehydrogenase type 1 and obesity
  J R Seckl and B R Walker, Western General Hospital, Edinburgh UK
• The role of peptide YY in the regulation of appetite and energy homeostasis
  D Boey and H Herzog, Garvan Institute of Medical Research, Sydney, Australia
• The metabolic syndrome as a modern maladaption syndrome
  T Funahashi, Osaka University Graduate School of Medicine, and Y Matsuzawa, Sumitomo Hospital, Osaka, Japan
• Aromatase and metabolic regulation
  E R Simpson, M E Jones, and C D Clyn, Prince Henry's Institute of Medical Research, Monash Medical Centre, Clayton, Australia
  Androgens in women – new treatments and perspectives
  W Arlt, University of Birmingham, Institute of Biomedical Research, UK
• Selective somatostatin analogs in treating pituitary tumors
  A Ben-Shlomo, K A Wawrowsky, and S Melmed, Cedars Sinai Research Institute, USA
• Glucocorticoid replacement: new facets to an old problem
  R J M Ross, University of Sheffield, Clinical Sciences Centre, UK
• Growth hormone replacement in adults – lessons learnt and future perspectives
  A Jostel, R D Murray, and S M Shalet, Christie Hospital, Manchester, UK
• Presentation of the 2005 Winner of the Eli Lilly HypoCCS Award: Professor Anthony P Heaney P C Sizonenko, Geneva, Switzerland
• Targeting pituitary tumors
  A P Heaney, Cedars-Sinai Research Medical Center, Los Angeles, USA

Subject areas: Endocrinology, Pituitary
Key words: Pituitary, growth and development, hormone interventions
Market: Clinicians, clinical researchers, lecturers and registrars in rheumatology or general medicine.